A new era of biopharma R&D: The TechBio revolution—realities and the next frontier

Join Tempus and Recursion leaders to explore their strategic TechBio partnership. Learn how they use AI and supercomputing with petabytes of data to accelerate drug discovery and development. See the impact on biopharma R&D's future.

Watch replay

Validating a novel target and informing trial design for a first-in-class therapeutic

Discover how a biopharma company used Tempus’ de-identified multimodal data to support validation of a novel target and inform trial design for a first-in-class therapeutic.

Read more

Guiding indication expansion with multimodal real-world data

Discover how a biopharma company used Tempus’ multimodal real-world data to guide its indication expansion strategy. See how our analysis of biomarker prevalence helped them identify new opportunities, prioritize R&D, and inform future trial design.

Read more